Ashley Woodruff
Primary Care · Savannah, GANPI 1518340496
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,711 of the $3,526 with a category attached, or 76.9%. 22 manufacturers reported payments, led by Edwards Lifesciences at 50.6% of the total. 2025 is the largest year on record at $2,079, 7.9 times the $264 reported in 2021.
Across 111 payments — averaging $31.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Edwards Lifesciences$2K
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$589
- Novartis$257
- Boehringer Ingelheim$141
- Philips North America LLC$110
- Amgen$98
- plus $547 from 16 others
What the payments were for
- Travel & lodging$81523%
- Food & beverage$2,71177%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Edwards Lifesciences | 25 | $1,784 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 24 | $589 |
| Novartis | 16 | $257 |
| Boehringer Ingelheim | 7 | $141 |
| Philips North America LLC | 6 | $110 |
| Amgen | 5 | $98 |
| Boston Scientific | 4 | $83 |
| Medtronic | 4 | $67 |
| Bayer | 4 | $62 |
| Abiomed | 1 | $48 |
| Actelion Pharmaceuticals US, Inc. | 2 | $41 |
| Averitas Pharma Inc. | 2 | $38 |
| Cardiva Medical, Inc. | 2 | $30 |
| Johnson & Johnson | 1 | $24 |
| Siemens Medical Solutions USA, Inc. | 1 | $23 |
| Pfizer | 1 | $21 |
| Alnylam Pharmaceuticals Inc. | 1 | $21 |
| Novo Nordisk | 1 | $19 |
| Abbott | 1 | $19 |
| AstraZeneca | 1 | $18 |
| E.r. Squibb & Sons, L.L.C. | 1 | $17 |
| Merck | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,526 in reported general payments places this provider in the 85th percentile of 235 primary care providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BrilintaTicagrelor | 42 | $24,117 |
| FarxigaDapagliflozin Propanediol | 18 | $10,130 |
| EliquisApixaban | 17 | $9,899 |
| ClopidogrelClopidogrel Bisulfate | 142 | $962 |
| Nitroglycerin PatchNitroglycerin | 12 | $451 |
| Bumetanide | 12 | $342 |
| Atorvastatin Calcium | 45 | $278 |
| Metoprolol Succinate | 44 | $198 |
| Amiodarone Hcl | 16 | $135 |
| Metoprolol Tartrate | 31 | $108 |
| Carvedilol | 32 | $79 |
| Furosemide | 29 | $74 |
| Cephalexin | 12 | $71 |
| Amlodipine Besylate | 22 | $27 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaBrilinta, Farxiga | $18 | $34,24760 claims |
| PfizerEliquis | $21 | $9,89917 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 235 primary care providers in Georgia.
Other primary care in Savannah
- Ashtyn ZaryckiSavannah$12K
- Pamela TurkDouglas$15K
- Morgan JonesLawrenceville$14K
- Jessi HaleColumbus$13K
- Meredith CarrAugusta$12K
- Zanetta BryantNewnan$11K
- Hannah CummingsSuwanee$9K
- Michelle LadewigGainesville$7K
- Lucia OcanoviciuCanton$7K
- Sarah NewGrovetown$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.